2021年4月1日

Japanese Healthcare
to the World-Activities of The Office for Global Strategy
of Medical Service and Health Industry, MHLW -Yosuke NAKAYAMAThe Office for Global Strategy
of Medical Service and Health Industry, MHLWIntroduction of the Office for Global Strategy of Medical Service and Health Industry, Ministryof Health, Labour and Welfare (MHLW）✓Established in 2013 based on PM Abe’s direction at the Headquarters forJapan's Economic Revitalization as follow:“ In order to accelerate innovation in the medical field as well, it is essential that there be the establishment of a control tower functioning

Background for the unified management of research and clinical studies as well as the unified allocation of research expenditures. I want the relevant
ministers to cooperate under the coordination of the Chief Cabinet Secretary to swiftly compile thorough, concrete policies. “✓Since then, implementing of policies in line with whole government’s
strategies / plans, such as The Africa Health and Wellbeing Initiative.

Facts

PrincipleofPolicies/Activities

Japan is one of the world's highest life expectancy countries based on:• Universal health care system• High-quality pharmaceuticals and medical devices• Quality of medical personnel, and the excellent service

Sharing knowledge/experience of Japan

Human resource
development,
aiming for improving
healthcare in developing
countries
Contribution to
Achievement of UHC

Nourish trust forJapanese healthcare
Systems/technologies/
equipment's

22

Overview of Human Resource Development =“TENKAI Project✓ MHLW conducts human resource development project regarding medical equipment,
pharmaceuticals, skills and systems & policies based on Japan’s experiences andtechnologies (“TENKAI” project) with NCGM （ National Center for Global Health and Medicine）

Governmentcommissioned project

1. Request for training anddispatch of trainers
2. Propose the program(public offering
competition)

4. Accept
4. Dispatch of
and/ortrainees
experts

3. Select and subsidize
the program✓Major training programs

・Public medical insurance system
・Hospital management expertise・Medical equipment operation technology
・Medical information system,and others

Hospital

Industry

University

3

Features of “TENKAI project”
1. Improvement of clinical services through human resources
development– Diagnosis (clinical examination, radiology and other diagnostic imaging, endoscopy,
cancer diagnosis, etc.)– Preventive and therapeutic technology (surgery, intensive care, blood transfusions,rehabilitation, dialysis, etc.)– Maintenance of medical devices– Quality medical services and patient safety,– Regulatory systems for pharmaceuticals and medical devices.

2. Aim to establish medical technology in partnership with Japanesecompanies and host countries’ actors in medical sector.
3. Complementary implementation with other partners / schemes
will result in synergies.

4. Speedy: decision-making process from the request to theimplementation.
4

4

TENKAI Project: 30 countries in the World,
7 countries in Africa since 2015

[Europe]Republic of Uzbekistan
Turkmenistan
Russian Federation[Middle East]
Islamic Republic of IranKingdom of Bahrain[Asia]
India
Republic of Indonesia
Republic of Korea
Kingdom of Cambodia
Republic of Singapore
Kingdom of Thailand
People's Republic of China
People's Republic of Bangladesh
Republic of the Philippines
Brunei Darussalam
Socialist Republic of Viet Nam
Malaysia
Republic of the Union of Myanmar
Mongolia
Lao People's Democratic Republic[Africa]• Federal Democratic Republic of Ethiopia• Republic of Ghana• Republic of Cameroon• Democratic Republic of the Congo• Republic of Zambia• United Republic of Tanzania• Federal Republic of Nigeria[Oceania]
Independent State of Papua New Guinea[Latin America]
Federative Republic of Brazil
United Mexican States

55

Examples of program in Africa - DR Congo Country: DR Congo
Area: Home medical/healthcare service by potable ultrasonic diagnostic device
Conducted by: SOIK Corporation
Cooperation with: MoH and public/private hospitals

Source/Picture :NCGM
https://kyokuhp.ncgm.go.jp/activity/open/R2pdf/2020_26_o19.pdf

6

6

Examples of program in Africa - Zambia
Country:
ZambiaAreas:
Rapid tuberculosis test kit = “PURE-TB-LUMP”
Conducted by: EIKEN CHEMICAL Co., LTD.
Cooperation with: MoH of Zambia and 11 medical centers various area

Picture:https://www.cas.go.jp/jp/seisaku/infection/activities/health/pdf/20190218_siryou1.pdf

Source/Picture :NCGM
https://kyokuhp.ncgm.go.jp/activity/open/R2pdf/2020_12_o02n.pdf

77

Examples of program in Africa - Zambia
Country: Zambia
Areas: CT Image Diagnosis
Conducted by: NCGM
Cooperation with: University Teaching Hospital of Zambia

Source/Picture: Secretariat of the TENKAI project88

Examples of program in Africa- Cameroon, DR Congo, Ethiopia, Ghana, Nigeria, and Zambia
Promoting the Understanding of WHO Pre-qualification System in African countries** Cameroon, DR Congo, Ethiopia, Ghana, Nigeria, and Zambia• Promoted understanding of pharmaceutical regulatory authorities in several Africancountries in the consistency of Japan’s PMDA certification with WHO PQs• Conducted public seminars for Japanese companies on UN procurement to sharepharmaceutical regulations in their countries by regulatory officials from African countries,
connecting international actors and Japanese actors
Drugs Authority (African countries)

Training
programNational Center
for Global Healthand Medicine(NCGM)

Pharmaceuticals
and Medical
Devices Agency(PMDA)
collaboration
WHO（ Pre-qualification
section ）Funded by MLHW, Japan, 2015-2019

99

Ref: Example of Activity other than TENKAI-Project
MHLW is supporting Japanese companies efforts on obtaining of approval of WHO's Prequalification in order topromote Japanese healthcare products in developing countries.
Example: Toyota Tsusho’s “Vaccine Vehicle”
Difficulties facing in developing countries• Rough roads disrupt the vaccine distribution by normal vehicles

Solution by Toyota Tsusho

The Vaccine Vehicle equipped with vaccine refrigerator which can be operated for 16 hrs without a power supply andcharged by the vehicle. Contribution to the effective use of vaccine.

10

Approval of WHO/PQ-S enables Toyota Tsusho’s Vaccine Vehicle to introduce into the African countries!

10